DOP01: A multi-centre study to explore the prevalence of Inflammatory Bowel Disease indicators in patients with moderate- to- severe psoriasis: Baseline results from the EPIC studyECCO'22Year: 2022
Authors: Hayee, B.(1);Ghosh, S.(2);Carter, B.(3);Bartlett, S.(4);Powles, E.(4);Millward, R.(4);Watcham, S.(4);Blanthorn-Hazell, S.(4);Crooks, J.(4);Hansell, C.(4);Millar, J.(5);Williams, C.(5);Migas, S.(5);Hajne, J.(5);Warren, R.(6);
(1)King's College Hospital NHS Foundation Trust, Gastroenterology, London, United Kingdom;(2)Cork University Hospital, Inflammatory Bowel Disease and Immunopathogenesis, County Cork, Ireland;(3)King's College London, Biostatistics and Health Informatics- Institute of Psychiatry- Psychology & Neuroscience, London, United Kingdom;(4)AbbVie Ltd., Medical, Maidenhead, United Kingdom;(5)NorthWest EHealth Limited, Data Analytics, Manchester, United Kingdom;(6)Salford Royal NHS Foundation Trust- Manchester NIHR BRC- University of Manchester, Dermatology, Manchester, United Kingdom;
DOP02: Increasing incidence of Inflammatory Bowel Disease in a high prevalence country: A nationwide study in FinlandECCO'22Year: 2022
Authors: Kontola, K.(1);Oksanen, P.(2,3);Huhtala, H.(4);Jussila, A.T.(2);
(1)The Hospital District of South Ostrobothnia, Department of Internal Medicine, Seinäjoki, Finland;(2)Tampere University Hospital, Department of Gastroenterology and Alimentary Tract Surgery, Tampere, Finland;(3)Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland;(4)Tampere University, Faculty of Social Sciences, Tampere, Finland;
DOP03: The use and efficacy of biological therapies 2010-2020 for Inflammatory Bowel Disease in a Danish tertiary centreECCO'22Year: 2022
Authors: Wewer, M.D.(1);Arp, L.(1);Melek, S.(1);Oluf Krautwald, F.(1);Vind, I.(1);Pedersen, G.(1);Nielsen, A.M.(1);Kiszka-Kanowitz, M.(1);Boysen, T.(1);Theede, K.(1);Nordgaard-Lassen, I.(1);Bendtsen, F.(1);Burisch, J.(1);
(1)Hvidovre Hospital, Gastro unit medical department, Copenhagen, Denmark;
DOP04: Inflammatory Bowel Disease (IBD) and Solid Organ Transplantation. Natural history of pre-existing and de novo IBD patients. (EITOS study of GETECCU)ECCO'22Year: 2022
Authors: Bastón Rey, I.(1);Calvino Suárez, C.(1);Luque, A.M.(2);Caballol, B.(3);Soutullo, C.(4);Bravo, A.(5);Castaño, A.(6);Gros, B.(7);Bernal, L.(8);Diz Lois, M.T.(9);Alonso Galán, H.(10);Cañete, F.(11);Castro, B.(12);Pérez Galindo, P.(13);González Muñoza, C.(14);El Hajra, I.(15);Martínez Montiel , P.(16);Alonso Abreu, I.(17);Mesonero, F.(18);González Vivo, M.(19);Peries, L.(20);Martín Arranz, E.(21);Abril, C.(22);Marín Jiménez, I.(23);Baltar, R.(24);Vicuna, M.(25);Moreno, N.(26);Brunet, E.(27);Rubín de Célix, C.(28);Fajardo, I.(29);Cruz, N.(30);Rojas Feria, M.(2);Fernández Clotet, A.(3);Gimeno, M.(4);Zabana, Y.(31);Suárez Ferrer, C.(21);Rodríguez Lago, I.(32);Barreiro de Acosta, M.(1);
(1)Hospital Clínico Universitario de Santiago De Compostela, Gastroenterology Department, Santiago De Compostela, Spain;(2)Hospital Universitario Virgen del Rocío, Gastroenterology Department, Sevilla, Spain;(3)Hospital Clinic de Barcelona, Gastroenterology Department, Barcelona, Spain;(4)Hospital Universitario y Politécnico La Fe, Gastroenterology Department, Valencia, Spain;(5)Hospital Regional Universitario de Málaga, Gastroenterology Department, Málaga, Spain;(6)Hospital Universitario Central de Asturias, Gastroenterology Department, Oviedo, Spain;(7)Hospital Universitario Reina Sofía, Gastroenterology Department, Córdoba, Spain;(8)Hospital General de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante ISABIAL, Gastroenterology Department, Alicante, Spain;(9)Complexo Hospitalario Universitario A Coruña, Gastroenterology Department, A Coruña, Spain;(10)Hospital Universitario Donostia and Biodonostia Health Research Institute, Gastroenterology Department, San Sebastián- Gipuzkoa, Spain;(11)Hospital Universitari Germans Trias i Pujol. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology Department, Barcelona, Spain;(12)Hospital Universitario Marqués de Valdecilla, Gastroenterology Department, Santander, Spain;(13)Complexo Hospitalario Universitario de Pontevedra, Gastroenterology Department, Pontevedra, Spain;(14)Hospital Santa Creu i Sant Pau, Gastroenterology Department, Barcelona, Spain;(15)Hospital Universitario Puerta de Hierro, Gastroenterology Department, Madrid, Spain;(16)Hospital Universitario 12 de Octubre, Gastroenterology Department, Madrid, Spain;(17)Hospital Universitario de Canarias, Gastroenterology Department, Tenerife, Spain;(18)Hospital Universitario Ramón y Cajal, Gastroenterology Department, Madrid, Spain;(19)Hospital del Mar, Gastroenterology Department, Barcelona, Spain;(20)Hospital Josep Trueta, Gastroenterology Department, Girona, Spain;(21)Hospital Universitario La Paz, Gastroenterology Department, Madrid, Spain;(22)Hospital Clínico Universitario de Valencia, Gastroenterology Department, Valencia, Spain;(23)Hospital General Universitario Gregorio Marañón, Gastroenterology Department, Madrid, Spain;(24)Hospital Universitario de Álava, Gastroenterology Department, Vitoria, Spain;(25)Complejo Hospitalario Universitario de Navarra, Gastroenterology Department, Navarra, Spain;(26)Hospital Doctor Peset, Gastroenterology Department, Valencia, Spain;(27)Hospital Universitari Parc Taulí, Gastroenterology Department, Sabadell, Spain;(28)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-IP, Gastroenterology Department, Madrid, Spain;(29)Hospital Universitari Mútua Terrasa, Gastroenterology Department, Barcelona, Spain;(30)Hospital Doctor José Molina Orosa, Gastroenterology Department, Lanzarote, Spain;(31)Hospital Universitari Mútua Terrasa. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology Department, Barcelona, Spain;(32)Hospital Universitario de Galdakao and Biocruces Bizkaia Health Research Institute, Gastroenterology Department, Galdakao, Spain;young GETECCU group
DOP05: Morbid obesity, a new susceptibility factor for developing Inflammatory Bowel Disease. Results of a population-based studyECCO'22Year: 2022
Authors: Canete Pizarro, F.C.(1);Vela, E.(2);Calafat, M.(1);Clèries, M.(2);Mañosa, M.(1);Domènech, E.(1);
(1)Germans Trias i Pujol University Hospital and CIBEREHD, Gastroenterology, Badalona, Spain;(2)Servei Català de la Salut- Generalitat de Catalunya, Unitat d’Informació i Coneixement, Barcelona, Spain;
DOP06: Antibiotics as a risk factor for older onset IBD: A population-based cohort studyECCO'22Year: 2022
Authors: Faye, A.(1);Allin, K.(2);Iversen, A.(2);Agrawal, M.(3);Faith, J.(4);Jean-Frederic , C.(3);Jess, T.(2);
(1)NYU Langone Health, Medicine, New York City, United States;(2)Aalborg University, Medicine, Copenhagen, Denmark;(3)Icahn School of Medicine- Mount Sinai Hospital, Medicine, New York City, United States;(4)Icahn School of Medicine- Mount Sinai Hospital, Genetics and Genomics Science, New York City, United States;
DOP07: Chronic abdominal pain in IBD patients in remission: Real-world data on contributing factorsECCO'22Year: 2022
Authors: Rezazadeh Ardabili, A.(1,2);Janssen, L.M.(1,2);Romberg-Camps, M.J.L.(3);Keszthelyi, D.(1,2);Jonkers, D.M.A.E.(1,2);van Bodegraven, A.A.(3);Pierik, M.J.(1,2);Mujagic, Z.(1,2);
(1)Department of Internal Medicine- Division of Gastroenterology and Hepatology, Maastricht University Medical Center+, Maastricht, The Netherlands;(2)School for Nutrition and Translational Research in Metabolism NUTRIM, Maastricht University Medical Center+, Maastricht, The Netherlands;(3)Department of Gastroenterology- Geriatrics- Internal and Intensive Care Medicine Co-MIK, Zuyderland Medical Centre, Heerlen-Sittard-Geleen, The Netherlands;
DOP08: Transcriptional signatures of blood derived immune cells associated with disease location-based heterogeneity in IBDECCO'22Year: 2022
Authors: Sudhakar, P.(1);Verstockt, B.(1,2);Cremer, J.(3);Verstockt, S.(1);Sabino, J.(1,2);Ferrante, M.(1,2);Vermeire, S.(1,2);
(1)KU Leuven, Department of Chronic Diseases- Metabolism and Ageing - TARGID, Leuven, Belgium;(2)University Hospitals Leuven, Department of Gastroenterology and Hepatology- KU Leuven, Leuven, Belgium;(3)KU Leuven, Department of Microbiology and Immunology- Laboratory of Clinical Immunology, Leuven, Belgium;
DOP09: Phenotypic and genetic determinants of medication response in patients in the UK IBD BioResourceECCO'22Year: 2022
Authors: Zhang, Q.(1);Fachal, L.(1);Shawky, R.(2);Lamb, C.(3,4);Parkes, M.(2,5,6);Anderson, C.(1);Raine, T.(1,6);
(1)Wellcome Trust Sanger Institute, Human Genetics, Cambridge, United Kingdom;(2)Cambridge University Hospitals NHS Foundation Trust, IBD BioResource- NIHR BioResource, Cambridge, United Kingdom;(3)Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle, United Kingdom;(4)Newcastle upon Tyne Hospitals NHS Foundation Trust, Department of Gastroenterology, Newcastle, United Kingdom;(5)University of Cambridge, Division of Gastroenterology and Hepatology- Department of Medicine, Cambridge, United Kingdom;(6)Cambridge University Hospitals NHS Foundation Trust, Department of Gastroenterology, Cambridge, United Kingdom;
DOP10: Intestinal Ultrasound at IBD diagnosis predicts major disease events – A Copenhagen IBD cohort studyECCO'22Year: 2022
Authors: Madsen, G.R.(1);Attauabi, M.(2);Wilkens, R.(1);Ilvemark, J.F.K.F.(2);Theede, K.(1);Bjerrum, J.T.(2);Dorn-Rasmussen, M.(3);Jansson, S.(3);Wewer, A.V.(3);Bendtsen, F.(1);Seidelin, J.B.(2);Boysen, T.(1);Burisch, J.(1);
(1)Hvidovre Hospital - University of Copenhagen, Gastrounit - Medical division, Hvidovre, Denmark;(2)Herlev University Hospital, Department of Gastroenterology and Hepatology, Herlev, Denmark;(3)Hvidovre Hospital - University of Copenhagen, The Paediatric Department, Hvidovre, Denmark;
DOP11: Early intestinal ultrasound predicts endoscopic response to anti-inflammatory treatment and shows drug-specific response to biologicals and tofacitinib in Ulcerative ColitisECCO'22Year: 2022
Authors: de Voogd, F.(1);Bots, S.(1);Van Wassenaer, E.(2);De Jong, M.(1);Pruijt, M.(1);Löwenberg, M.(1);D'Haens, G.(1);Gecse, K.(1);
(1)Amsterdam University Medical Center, Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Emma Children's Hospital- Amsterdam University Medical Center, Pediatric Gastroenterology, Amsterdam, The Netherlands;
DOP12: Non-invasive assessment of intestinal inflammatory activity in Ulcerative Colitis by Multispectral Optoacoustic Tomography (MSOT)ECCO'22Year: 2022
Authors: Klett, D.(1);Jesper, D.(1);Vitali, F.(1);Federle, A.(1);Atreya, R.(1);Strobel, D.(1);Leppkes, M.(1);Neufert, C.(1);Rath, T.(1);Neurath, M.F.(1);Waldner, M.J.(1);
(1)University Hospital Erlangen-Nuremberg, Department of Medicine I, Erlangen, Germany;
DOP13: The Arborisation index: An MRI-based measure of mesenteric hyperaemia in Crohn’s DiseaseECCO'22Year: 2022
Authors: Naim, I.(1,2);Darie, A.M.(1,2);Hoad, C.(2,3);Gowland, P.(2,3);Moran, G.W.(1,2);
(1)University of Nottingham, School of Medicine, Nottingham, United Kingdom;(2)Nottingham University Hospitals NHS Trust and University of Nottingham, National Institute of Health Research- Nottingham Biomedical Research Centre, Nottingham, United Kingdom;(3)University of Nottingham, School of Physics and Astronomy, Nottingham, United Kingdom;
DOP14: Validation of a new OPtical diagnosis Training platform to Improve dysplasia Characterisation in Inflammatory Bowel Disease (OPTIC-IBD): A multicentre randomised controlled studyECCO'22Year: 2022
Authors: Iacucci , M.(1,2);Ingram , R.J.M.(1,2);Bazarova , A.(3);Cannatelli , R.(4);Labarile , N.(5);Nardone , O.M.(6);Parigi , T.L.(1,7);Siau , K.(8);Smith , S.C.L.(1);Ferraz , J.G.P.(2);Kiesslich , R.(9);Panaccione , R.(2);Parra-Blanco , A.(10);Tontini , G.E.(11,12);Uraoka , T.(13);Ghosh , S.(14);
(1)University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, United Kingdom;(2)University of Calgary, Cumming School of Medicine, Calgary, Canada;(3)University of Cologne, Institute for Biological Physics, Köln, Germany;(4)University of Milan ASST Fatebenefratelli Sacco, Department of Biochemical and Clinical Sciences 'L Sacco', Milano, Italy;(5)National Institute of Research 'Saverio De Bellis', Section of Gastroenterology, Castellana Grotte, Italy;(6)School of Medicine Federico II of Naples, Gastroenterology Unit- Department of Clinical Medicine and Surgery, Napoli, Italy;(7)Humanitas University, Department of Biomedical Sciences, Milano, Italy;(8)Royal Cornwall Hospitals NHS Trust, Department of Gastroenterology, Truro, United Kingdom;(9)Helios Horst-Schmidt-Kliniken Hospital, Division of Gastroenterology, Wiesbaden, Germany;(10)Nottingham University Hospitals NHS Trust, Department of Gastroenterology, Nottingham, United Kingdom;(11)University of Milan, Department of Pathophysiology and Organ Transplantation, Milano, Italy;(12)Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Gastroenterology and Digestive Endoscopy Unit, Milano, Italy;(13)Gunma University Graduate School of Medicine, Department of Gastroenterology and Hepatology, Maebashi, Japan;(14)University College Cork, APC Microbiome Ireland, Cork, Ireland;OPTIC-IBD Study Group
DOP15: Fluorescent labelled vedolizumab for real-time visualization and quantification of local drug distribution and pharmacodynamics in Inflammatory Bowel Diseases during endoscopyECCO'22Year: 2022
Authors: Gabriëls, R.Y.(1);Linssen, M.(1);van der Waaij, A.(1);Volkmer, P.(1);Hooghiemstra, W.(1);Kats-Ugurlu, G.(2);Robinson, D.(3);Dijkstra, G.(1);Nagengast, W.(1);
(1)University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;(2)University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands;(3)University Medical Center Erasmus Rotterdam, Optic Diagnostics and Therapy, Rotterdam, The Netherlands;
DOP16: Categorizing endoscopic severity of Crohn’s Disease using the Modified Multiplier SES-CD (MM-SES-CD)ECCO'22Year: 2022
Authors: Narula, N.(1);Pray, C.(1);Wong, E.(1);Colombel, J.F.(2);Marshall, J.(1);Daperno, M.(3);Reinisch, W.(4);Dulai, P.(5);
(1)McMaster University, Department of Medicine Division of Gastroenterology, Hamilton, Canada;(2)Icahn School of Medicine at Mount Sinai, Division of Gastroenterology, New York, United States;(3)AO Ordine Mauriziano di Torino, Gastroenterology Unit, Turin, Italy;(4)Medical University of Vienna, Department of Internal Medicine III Division of Gastroenterology and Hepatology, Vienna, Austria;(5)University of California San Diego, Division of Gastroenterology, La Jolla, United States;
DOP17: Evaluating segmental healing with the modified Mayo endoscopic score (MMES) has a clear additional value in predicting long-term outcome in patients with Ulcerative Colitis: Results from a prospective cohort studyECCO'22Year: 2022
Authors: Lenfant, M.(1,2);Verstockt, B.(1,2);Sabino, J.(1,2);Vermeire, S.(1,2);Ferrante, M.(1,2);
(1)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(2)KU Leuven, Translational Research in Gastrointestinal Disorders, Leuven, Belgium;
DOP18: Advanced optical diagnosis technology for assessment of endoscopic and histological remission in Ulcerative Colitis: A systematic review and meta-analysisECCO'22Year: 2022
Authors: Nardone, O.M.(1);Snir , Y.(2,3);Hodson, J.(4);Cannatelli, R.(1);Labarile, N.(1);Siau, K.(1,5);Hassan, C.(6);Yanai, H.(2,3);Dotan, I.(2,3);Ghosh, S.(1,7,8,9);Iacucci, M.(1,8,9);
(1)University of Birmingham, Institute of Translational Medicine and Institute of Immunology and Immunotherapy, Birmingham, United Kingdom;(2)Rabin Medical Center- Beilinson Campus- Petach-Tikva Israel, Division of Gastroenterology, Petach-Tikva, Israel;(3)Tel Aviv University- Tel Aviv- Israel, Sackler Faculty of Medicine, Tel Aviv, Israel;(4)University Hospitals Birmingham NHS Foundation Trust- Birmingham- UK., Department of Health Informatics-, Birmingham, United Kingdom;(5)Royal Cornwall Hospitals NHS Trust- Truro- UK, Department of Gastroenterology-, Truro, United Kingdom;(6)Nuovo Regina Margherita Hospital- Roma- Italy, Department of Gastroenterology, Rome, Italy;(7)University College Cork- Cork- Ireland, APC Microbiome Ireland- College of Medicine and Health, Cork, Ireland;(8)University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, NIHR Biomedical Research Centre, Birmingham, United Kingdom;(9)University Hospitals Birmingham NHS Trust- Birmingham- UK, NIHR Wellcome Trust Clinical Research Facilities, Birmingham, United Kingdom;
DOP19: Myeloid and lymphoid cell abnormalities persist in the intestinal mucosa of patients who recover from COVID-19 infectionECCO'22Year: 2022
Authors: Meringer, H.(1);Tokuyama, M.(1);Tankelevich, M.(1);Martinez-Delgado, G.(1);Jha, D.(1); Livanos, A.E.(1);Canales-Herrerias, P.(1);Cossarini, F.(2);Mehandru , S.(1);
(1)Icahn School of medicine at Mount Sinai, Division of Gastroenterology- Department of Medicine, New York, United States;(2)Icahn School of medicine at Mount Sinai, Division of Infectious Disease- Department of Medicine, New York, United States;
DOP20: Functional viral neutralisation responses after SARS-CoV-2 infection in Inflammatory Bowel Disease patients receiving infusion therapies: Report from the ICARUS-IBD ConsortiumECCO'22Year: 2022
Authors: Wellens, J.(1,2);Edmans, M.(3);Obolski, U.(4,5);Marlow, L.(1);Brann, S.(1);Dunachie, S.(3,6,7);Eyre, D.(8,9);Helmus, D.(10);Barnes, E.(1,3);Colombel, J.F.(10);Wong, S.Y.(10);Klenerman, P.(1,3);Lindsay, J.O.(11,12);Thompson, C.P.(13);Satsangi, J.(1);
(1)University of Oxford, Translational Gastro-Intestinal Unit- Nuffield Department of Medicine, Oxford, United Kingdom;(2)University hospitals Leuven, Translational Research for Gastrointestinal Diseases, Leuven, Belgium;(3)University of Oxford, Peter Medawar Building for Pathogen Research, Oxford, United Kingdom;(4)Tel-Aviv University, Porter School of Environmental and Earth Sciences- Faculty of Exact Sciences, Tel-Aviv, Israel;(5)Tel-Aviv University, School of Public Health- Faculty of Medicine, Tel-Aviv, Israel;(6)Oxford University Hospitals- NHS, Department of Microbiology/Infectious Diseases, Oxford, United Kingdom;(7)University of Oxford, Centre for Tropical Medicine and Global Health- Nuffield Department of Medicine, Oxford, United Kingdom;(8)University of Oxford, Big Data Institute, Oxford, United Kingdom;(9)University of Oxford, Infectious Diseases & Medical Microbiology, Oxford, United Kingdom;(10)Icahn School of Medicine at Mount Sinai- New York, The Henry D. Janowitz Division of Gastroenterology- Department of Medicine, New York, United States;(11)The Royal London Hospital, Barts Health NHS Trust- department of Gastroenterology, London, United Kingdom;(12)Blizard Institute- Barts and the London School of Medicine Queen Mary University of London, Centre for Immunobiology, London, United Kingdom;(13)University of Oxford, Department of Zoology, Oxford, United Kingdom;The ICARUS-IBD CONSORTIUM
